Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1/Th17 cells

Imiquimod (IMQ), a Toll-like receptor (TLR) 7/8 agonist, has been used to treat various skin neoplasms, including genital warts, actinic keratoses and superficial basal cell carcinomas. Although IMQ has been recognized to activate both innate and adaptive immunity, the underlying mechanism(s) by whi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Yokogawa, Maki, Takaishi, Mikiro, Nakajima, Kimiko, Kamijima, Reiko, DiGiovanni, John, Sano, Shigetoshi
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3397281/
https://ncbi.nlm.nih.gov/pubmed/22431065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.21901
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares